ISN Journal Summaries on Immunosuppression Treatments for Glomerular Disease and Blood Disorders With Kidney Involvement
Kidney International® Evaluating the Risk of Cardiovascular Events Associated With Different Immunosuppression Treatments for Glomerular Diseases This study analyzed 1,912 adults with glomerular disease from Canada to evaluate the cardiovascular risks associated with immune therapies used for treatment. The findings reveal that prolonged exposure to calcineurin inhibitors and cyclophosphamide is linked to a higher risk of...